Theralase Technologies Inc. (TLTFF)

Theralase Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	59	46	30	51	61	30
Market Cap Growth	25.43%	50.74%	-40.86%	-15.43%	98.73%	-43.12%
Enterprise Value	59	46	30	50	57	24
Last Close Price	0.23	0.18	0.14	0.25	0.29	0.15
PS Ratio	81.40	63.54	37.35	60.85	98.13	41.77
PB Ratio	74.57	31.76	20.98	22.40	15.11	4.24
P/TBV Ratio	74.57	31.76	20.98	22.40	15.11	4.24
EV/Sales Ratio	79.66	63.53	37.52	59.13	91.82	32.43
Debt / Equity Ratio	0.29	0.14	0.20	0.15	0.01	0.01
Asset Turnover	0.32	0.32	0.29	0.23	0.10	0.07
Inventory Turnover	0.82	0.80	0.89	0.97	0.92	1.17
Quick Ratio	0.50	0.99	0.60	2.86	4.56	10.18
Current Ratio	0.83	1.61	1.39	3.67	5.71	10.85
Return on Equity (ROE)	-269.41%	-214.26%	-182.91%	-128.27%	-61.98%	-48.64%
Return on Assets (ROA)	-88.50%	-82.17%	-77.21%	-64.71%	-35.56%	-28.06%
Return on Capital Employed (ROCE)	-365.60%	-189.70%	-208.90%	-150.40%	-89.60%	-62.20%
Earnings Yield	-5.34%	-6.48%	-11.43%	-7.56%	-5.76%	-14.42%
FCF Yield	-3.21%	-5.10%	-10.28%	-7.47%	-5.39%	-11.88%
Buyback Yield / Dilution	-8.38%	-9.14%	-5.79%	-1.79%	-	-41.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.